MDxHealth affirms FY2026 sales guidance at $110.0M–$115.0M
MDxHealth (NASDAQ: MDXH) affirms FY2026 sales guidance of $110.000M–$115.000M versus a $98.814M estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.